Modernizing Medicare Advantage for the Next Generation of Seniors
The Centers for Medicare & Medicaid Services (CMS) took constructive steps in its 2027 final…
Modernizing Medicare Advantage for the Next Generation of Seniors
The Centers for Medicare & Medicaid Services (CMS) took constructive steps in its 2027 final rule and rate announcement, particularly on payment integrity and quality measurement. But those steps are not the finish line. Policymakers should further modernize MA to strengthen competition, transparency and accountability. Here’s where to start. The post Modernizing Medicare Advantage for…
OHSU’s Bill Hersh, M.D., to Receive AMIA’s Collen Award
Informatics leader conceptualized and implemented the first offering of the AMIA 10×10 program
How TrumpRx Brand-Name Drug Prices Compare to Other Countries
TrumpRx prices for brand-name drugs are about as likely to be higher as lower compared to average prices in other wealthy countries, according to an analysis that compares 32 brand-name drugs (without generics or biosimilars) on the TrumpRx website with publicly available prices in one or more of 11 OECD member countries.
Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive
Consumers who buy brand-name prescription drugs without an available generic or biosimilar at the prices available through the new TrumpRx website are about as likely to pay more as pay less for those drugs relative to the publicly listed prices available in other comparatively wealthy countries, a new KFF analysis finds.
KFF Women’s Health Survey Explores How Women Navigate Contraceptive Information — The Monitor
Many reproductive-age women seek health information through online sources, where they may encounter false or misleading information about contraception, according to the 2026 KFF Women’s Health Survey. And an Ohio health department’s new AI policy offers a rare example of a health-specific policy addressing accuracy and public trust.
Black Lung Disease Remains a Threat, but Federal Officials Delay Effort To Address It
OAK HILL, W.Va. — Each day at New River Health in Oak Hill, Lisa Emery finds disheartening signs of what she describes as a slow-motion repeat of the Hawks Nest Tunnel disaster. Emery is director of New River’s Breathing Center and chair of the National Coalition of Black Lung and Respiratory Disease Clinics. The disaster…
DeSantis Discusses COVID-19, Rural Healthcare and Medicaid Fraud at Oracle Summit
At the Oracle summit, Gov. Ron DeSantis discussed lessons from COVID-19, Florida’s rural healthcare investments, Medicaid fraud and the potential of targeted AI applications
Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`
Roche reported the drug sefaxersen achieved statistically significant and clinically meaningful results in a Phase 3 test in immunoglobulin A nephropathy, or IgAN. This antisense oligonucleotide, which came from Ionis Pharmaceuticals, could offer advantages over other drugs currently available for treating this rare chronic disease of the kidneys. The post Phase 3 Data Could Make…
CMS Administrator Mehmet Oz Discusses AI, Prior Authorization and Innovation
Mehmet Oz shared CMS’s perspective on AI, faster innovation, prior authorization
Addus Paying $275M For AccentCare’s Personal Care Division
CFO Brian Poff told a recent conference that the Texas-based company is looking to strike other significant deals in the near future.
